FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

29990511000001106: Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93621701000001112 Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93621801000001115 Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Is a Alendronic acid 10mg tablets true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Is a Alendronic acid 10mg tablets false Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely alendronic acid 10 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Alendronic acid false Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Alendronate sodium true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alendronic acid true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Alendronic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP True Alendronic acid 10mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start